Technology and Innovation

SmartRD is NoRD Bio’s proprietary assay designed to redefine cancer monitoring, which combines advanced technologies to deliver unparalleled performance:

• Cell-free (cf) DNA Analysis: Harnesses tumor-derived DNA fragments circulating in biofluids.
• Epigenetic Signatures: Unlocks critical insights from epigenomic patterns for precise disease characterization.
• Reliable AI/ML Models: Integrates robust artificial intelligence and machine learning algorithms to enhance accuracy, predict outcomes, and provide actionable insights.

With SmartRD, NoRD Bio offers an innovative, efficient, and transformative solution for monitoring disease progression and response to treatment.